четверг, 16 марта 2017 г.

Why Bill Ackman's Valeant exit is not a sell signal for investors

Why Bill Ackman's Valeant exit is not a sell signal for investors


Investors widely interpreted Bill Ackman's abrupt exit from Valeant Pharmaceuticals International Inc. this week as a loss of faith - and, therefore, yet another sell signal for the beleaguered shares. But there was a compelling reason for the trade, regardless of the company's prospects: The tax benefit to Mr. Ackman's hedge fund greatly exceeded what it would likely gain by sticking it out with the company.



from Biotech News